Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT)

Bone Marrow Transplantation

Volumn 37, Issue 4, 2006, Pages 393-401

  Stiff, P J ^a   Erder, H ^b   Bensinger, W I ^c   Emmanouilides, C ^d   Gentile, T ^e   Isitt, J ^f   Lu, Z J ^f   Spielberger, R ^g  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b Forest Laboratories   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f AMGEN INC   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Oral mucositis; Palifermin; Patient reported outcomes; Validation

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; NARCOTIC ANALGESIC AGENT; PALIFERMIN; PLACEBO;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRINKING; DRUG MEGADOSE; EATING; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; ORAL MUCOSAL DISEASE; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SCORING SYSTEM; SELF REPORT; SLEEP; SORE THROAT; SWALLOWING; TOTAL PARENTERAL NUTRITION; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 7; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PAIN; PATIENT COMPLIANCE; PLACEBOS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STOMATITIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 32844454915     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705250     Document Type: Article

References (19)

1. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33-39.
2. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor CR et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000; 110: 292-299.
3. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 1993; 20: 1493-1502.
4. Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993; 72: 1612-1617.
5. Sonis ST. A biological approach to mucositis. J Support Oncol 2004; 2: 21-32; discussion 35-36.
6. Alvarado Y, Bellm LA, Giles FJ. Oral mucositis: Time for more studies. Hematology 2002; 7: 281-289.
7. Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: Oral mucositis patient provider advisory board. Cancer Invest 2002; 20: 793-800.
8. World Health Organization. A Handbook for Reporting Results of Cancer Treatment. World Health Organization: Geneva, 1979.
9. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
10. Olson K, Hanson J, Hamilton J, Stacey D, Eades M, Gue D et al. Assessing the reliability and validity of the revised WCCNR stomatitis staging system for cancer therapy-induced stomatitis. Can Oncol Nurs J 2004; 14: 168-174, 176-182.
11. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett Jr WH, Mulagha MT et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85: 2103-2113.
12. Etiz D, Orhan B, Demirustu C, Ozdamar K, Cakmak A. Comparison of radiation-induced oral mucositis scoring systems. Tumor 2002; 88: 379-384.
13. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, December 12, 2003. Available online: http://ctep. cancer.gov/reporting/ctc.html. Accessed October 5, 2004.
14. Dorr W, Spekl K, Farrell CL. Amelioration of acute oral mucositis by keratinocyte growth factor: Fractionated irradiation. Int J Radiat Oncol Biol Phys 2002; 54: 245-251.
15. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590-2598.
16. Cella D, Eton DT, Lai J-S, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002; 24: 547-561.
17. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000; 18: 419-423.
18. Nunnally J, Bernstein I. Psychometric Theory, 3rd edn. 1994, pp 264-266.
19. Donaldson GW. The factorial structure and stability of the McGill Pain Questionnaire in patients experiencing oral mucositis following bone marrow transplantation. Pain 1995; 62: 101-109.